Kinvard Bio, Inc.
- Biotech or pharma, therapeutic R&D
Kinvard Bio is a spin-out company from the Myers Lab at Harvard University’s Department of Chemistry and Chemical Biology, committed to developing a new, highly differentiated ribosome-targeting IV / Oral therapeutic class to treat challenging acute and chronic bacterial infections.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}